This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk04: Good afternoon. My name is Chris, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Skywater Technology First Quarter 2022 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you'd like to ask a question during this time, simply press star, then the number one on your telephone keypad. To withdraw your question, please press star one again. Thank you. Claire McAdams. and best relations with Skywater, you may begin.
spk00: Good afternoon, and welcome to Skywater's first quarter fiscal 22 conference call. With me on the call today from Skywater are Thomas Sonderman, President and Chief Executive Officer, and Steve Manko, Chief Financial Officer. I'd like to remind you that our call is being webcast live on Skywater's investor relations website at ir.skywatertechnology.com. The webcast will be available for replay shortly after the call concludes. During the call, any statements made about our future financial results and business are forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause our actual results to differ materially. For a discussion of these risks and uncertainties, please refer to our filings with the Securities and Exchange Commission, including our earnings release filed on Form 8-K today and our fiscal 2021 10-K filed on March 10th. All forward-looking statements are made as of today, and we assume no obligation to update any such statements. During the call, we will discuss non-GAAP financial measures. you can find a reconciliation of these non-GAAP financial measures to GAAP financial measures in our earnings release, which is available on our investor relations website. Unless otherwise noted, all comparable periods referenced today are versus the prior year or the first quarter of fiscal 2021. With that, I'll turn the call over to Tom.
spk02: Thank you, Claire, and good afternoon to everyone on the call. Today we are pleased to report total Q1 sales of $48 million. While GAAP reported revenues were essentially flat year-over-year, total revenues, excluding tool sales, were up 44%.
spk01: This reflects advanced technology program sales, our ATS growth of 13%, and 115% growth in wafer services.
spk02: This was higher than forecasted for Q1 due to the completion of our new contract with Infineon, which is our largest historical customer, and the associated impact on our GAAP results. Per the AK filed at the end of the quarter, the revised contract terms reflect a significant price increase as well as a change in revenue recognition. with wafer revenues being recognized over time instead of when shipped for inventory within the quarter, and all at the higher price level. The result was Q1 revenue upside of approximately $8 million, which was more than offset by higher costs attributed to this WIP inventory, resulting in a slightly negative reported gross margin for the quarter. With improving pricing and volume momentum, our non-GAAP gross margin was positive, and would have been even higher without this impact. While the accounting impact resulted in significant upside in our Q1 revenues, our prior growth forecast for the recognition of all WIP revenue in Q1 is effectively a pull-in of expected finished wafer sales from the next couple of quarters.
spk01: This contract recognizes the value skyrocketed.
spk02: and is a key element of our strategy to drive permanent pricing expansion. It also means that our overall business is being valued at a higher level than it was previously, and products continue to have value and a growth path in the market, which gives us confidence as we seek to diversify and grow our customer portfolio. To that end, we continue to work to securing long-term agreements across all market verticals as we create an increasingly robust sales pipeline.
spk01: In fact, as we enter the second quarter, which means we have effectively reset our recalibrated, our revenue level at these outputs. We have moved into Q2 and beyond. As we move into Q1, we expect to deliver on sequential improvements in revenue output throughout the forthcoming quarters as a result our confidence has increased that we can achieve revenue the pay-as-you-go model with revenues being recognized over time will result in more visibility and less volatility in our quarterly results in q1 we continue to
spk02: to win new business, signing three new ATS programs and three new wafer services customers. Importantly, we are consistent with our prior target of achieving positive gross margins at the mid $40 million revenue level. Key to our gross margin expansion is that we expect to grow revenues from this baseline without incurring the same level of additional costs given the fixed cost nature of our business.
spk01: Non-GAAP gross margin was a positive 1.0 to negative 6.1% in Q2. To aid in the comparability of our gross margin, adjust for equity-based material before the IPO, as well as the impact of unusual or episodic items.
spk02: such as the inventory write-off in Q4 and tool sales, which typically is pass-through revenue, but unique to Q1 of last year, was highly profitable. We are pleased with the progress made in Q1 to show sequential improvement and return to positive gross margins. The lower margin compared primarily reflects the negative margin on the WIP inventory pull-in and hiring costs associated with maintenance.
spk01: manufacturing labor, higher costs associated with managing through the industry's supply chain constraints, and increased investments in our strategic platforms. As demand for our technology as a service model increases, we have continued to hire at our fabs to support increased activities.
spk02: In late April, Fed Chairman Jerome Powell described the job market as extremely tight and unsustainably hot, with wages rising at their fastest pace in decades. Manufacturing labor turnover rates, equipments, chemicals, and gases remains congested with rising prices. Freight costs especially are increasing above the already elevated rates we witnessed in Q4. We have been able to resolve multiple supply chain issues by dual sourcing gas supplies and qualifying new vendors. We have resolved the supply of neon, helium, nitrogen, and hydrogen, but prices are elevated.
spk01: While a small part of our overall material costs in the case of neon, prices are up 13x.
spk02: We are watching the market closely as other materials become issues to resolve. Gases, chemicals, parts, wages, hiring, and other areas seeing price inflation will continue to be a focus. Our cost of revenue also contains strategic long-term investments in our radiation-hardened and heterogeneous integration platforms. In addition, we have continued R&D investments to build capabilities in our targeted growth platforms, including power. Adjusted EBITDA was at negative $4.8 million in the first quarter. Now, starting with biohealth. Last quarter, we discussed our exciting partnership with Rockley Photonics.
spk01: Continuing their momentum, in Q1, they entered a development partnership with Medtronic,
spk02: to expand their biomarking sensing platform for wearable devices in the inpatient care market. Rockne is engaged with multiple wearable and medical device customers and continues to announce new products. Importantly for Skywater, our Rockne revenues grew sequentially in Q1 as we progress through our Minnesota and our Florida locations. Our other biohealth programs continue to progress in manufacturing readiness as several significant design milestones were completed in the quarter on the path towards upcoming regulatory approvals needed for production ramps anticipated to initiate later this year. In our mixed signal and power management category, Skywater and Infineon have fully executed new volume manufacturing agreements, extending our existing engagement for mixed signal ASIC production. As I noted earlier, these include an adjustment to current market pricing on core and legacy platforms, as well as more favorable manufacturing commitments through a new non-cancellable order structure. Improved pricing on legacy business is an important milestone, but we continue to focus our efforts in strategic growth areas that are accretive to gross margin. Our customer and technology partner, Applied Novel Devices, or ANV, presented their breakthrough MOSFET technology at the annual APEC conference in Houston in March. The technology has been recognized by numerous product design groups since that time for its GAN-like performance and ideal characteristics for enabling efficient power conversion. We see growing engagement in several application areas for this technology as we march towards our production ramp this fall. We continue to make good progress in all three elements of our heterogeneous integration technology roadmap, which we previously referred to as advanced packaging. This includes silicon interposers, fan-out wafer-level packaging, and wafer binding. The FAB continues to progress towards production readiness, as indicated by the completion of our ISO 9001 qualification in the first quarter.
spk01: Last quarter, we reported on the first silicon milestone for our DOD-funded IBAS silicon Interposer program.
spk02: This continues to progress ahead of schedule. Phase one qualification lots are in line and expected to come out in the coming weeks, which will be a major milestone enabling further customer engagement based on our qualified test vehicle demonstration. Subsequent program milestones will focus on qualifying TSVs and incorporating backside redistribution layers and passive circuit devices, which will enhance our capabilities for more sophisticated multi-chip module and high-frequency solutions. We also initiated a project to fabricate DECA Technologies N-series test vehicles, which are a key aspect of our market and customer development efforts. The test vehicles will represent a basic architecture that leverages DECA's disruptive adaptive patterning technology and is a key enabler for achieving state-of-the-art fine-pitch or fan-out wafer-level packaging integrations. The current project plan is for the test vehicle data package to be completed and available for customers later this year. Skywater is continuing to advance our capabilities in wafer-to-wafer bonding technology through a partnership with a major equipment vendor. We are looking for bonding tool qualification in Q2 and begin supporting customer applications. We view this as a critical pillar of our heterogeneous integration technology platform and a key building block for developers to develop secure, state-of-the-art 2.5D and 3D technology solutions. Rad hard progress throughout Q1 set the conditions for the conclusion of of the development phase at the beginning of Q2 with a highly anticipated award for the production and qualification phase beginning in Q3. We continue to expect Rathard revenues to begin to ramp as 2022 unfolds. This includes additional follow-on activities that will bridge the gap between the phases as we work with our industry Rathard IP library and open source enabled design solutions. One major benefit we expect to realize as we move our RADHAR platform from development to production is the ability to leverage the state-of-the-art capability in the commercial markets, specifically those requiring radiation-tolerant capabilities, which are not as stringent as our government-sponsored programs. Our LEO, our Low Earth Orbit Strategy, will be focused on civil and commercial space opportunities over the coming months. This is a notable example of how we will leverage our strategic Rathard investments and manufacturing capacity to deliver high-margin products into the commercial space. Also in Q1, we announced a collaboration with QuickLogic for Rathard FPGAs, further expanding our design ecosystem for advanced extreme environment solutions. Moreover, customers producing Rathard devices at Skywater will benefit from our decades-long heritage of commercially-focused manufacturing for demanding end markets and high-quality standards for low and high-volume designs. Finally, the continued commitment by the President, the Senate Majority Leader, the Speaker of the House, and members of the minority party to pass final legislation containing federal incentives has never been more important for our country. is imperative for a balanced supply chain that the U.S. government enact this critical legislation promptly. In addition to responding to recent inquiries from the Department of Commerce on the administration of the grant program, the Skywater team has been collaborating with its partners and the DOD to respond to their own request for information as they contemplate activities to bolster the domestic semiconductor supply chain and strengthen the defense industrial base. As the only U.S.-owned pure-plate foundry, elected officials and policymakers continue to reach out to Skywater to better understand our technologies, the workforce development initiatives we are leading in Minnesota and Florida, and how their decisions will enable the successful restoring of this crucial industry. In recent weeks, we have met with members of Congress from Minnesota, Florida, and Texas, as well as the Governor of Michigan, to discuss how we can rebuild America's leadership in advanced manufacturing. To summarize, our 25% growth objective incorporates three elements of revenue appreciation, meeting technology development milestones and achieving better pricing, transitioning more of our technology programs to volume production, and achieving greater fab efficiency. We made progress on all these fronts in Q1 and still have plenty of room for continued growth as we progress through the year. Our strategy is built around transitioning to higher value and higher margin per way for business, not solely pure volume increases. Our Q1 activities and results demonstrate progress towards this strategy. While concerns around semiconductor industry softness are pervasive and incessant, It is important to note that the primary areas of softness, such as consumer-driven smartphone and PC demand, are not material markets for Skywater. Our strategic growth areas, such as biohealth, extreme environment microelectronics and superconducting, and automotive power and IoT, are continuing to see strong and growing levels of investment and excitement. The amazing work being done by the employees of Skywater is critical to our customers, our shareholders, and our nation. We will continue to decisively invest in our rad-hard power and heterogeneous integration platforms to fuel future growth and further our ability to co-create the technologies of the future with our customers in a post-Moores law era. For 2022, our progress in Q1 provides increased confidence for revenue growth near our long-term goal of 25%. This is supported by continued expansion of our sales pipeline, important program design wins, and the expected progress of our biohealth, power management, and radiation-hardened platforms moving beyond development towards prioritization. The expected revenue growth in 2022, coupled with our new baseline revenue level at improved pricing, have established positive gross margins in the mid-$40 million revenue range and positions us well for gross margin expansion later this year. I will now turn the call over to Steve for more information on Skywater's financial performance in our recently completed quarter.
spk03: Thank you, Tom. Total revenue for the first quarter of 2022 was $48.1 million, which was essentially flat year over year, and up 25% sequentially from the fourth quarter. Advanced technology services revenue was $26.6 million, and wafer services revenue was $21.5 million. There are a couple of important adjustments to make when comparing our revenue performance to prior periods. First, ETS revenue in the first quarter of 2022 included just $1 million of tool revenue compared to an unusually high $15.4 million of tool revenue in the first quarter of 2021. Second, Wafer services revenue in the first quarter of 2022 included the pull-in of $8.2 million of revenue related to the new frame agreement with Infineon. This pull-in of revenue is due to an accounting adjustment in the first quarter related to the now non-cancellable nature of purchase orders from this customer. Effective April 1st of this year, Skywater recognizes revenue over time as the wafers are being fabricated. Prior to April 1st, Skywater was recognizing wafer services revenue for this customer at a point in time, such as when the wafers were shipped. Given the April 1st effective date, which was before our fiscal quarter end of April 3rd, this necessitated a one-time accounting adjustment to recognize overtime revenue for the Infineon-related work in process or WIP inventory. Excluding the WIP revenue adjustment, which was an acceleration of revenue from future quarters and at higher prices, wafer services revenue would have been $13.2 million, up 33% year-over-year on a comparable basis. Excluding tool revenues, ATS revenue of $25.6 million was up 13% year-over-year. Increased revenue in both ATS and wafer services continues to track well against our revenue growth targets for 2022 as we continue to ramp production and win new customers and programs. Gap cost of revenue was $49.1 million, an increase of 26% year-over-year. non-GAAP costs of revenue, which adjusts for cost of tool sales, equity-based compensation, and Florida startup costs, as well as the inventory write-down, was $46.6 million in the first quarter of 2022, up 61% from $28.9 million in the first quarter of 2021. So while GAAP gross loss was $0.9 million in for a negative 2% gross margin, non-GAAP gross profit in the quarter turned positive at $0.5 million for a non-GAAP gross margin of 1.1%. While we are pleased with our progress returning to positive gross margins, our ongoing costs of revenue continue to be impacted by increased costs associated with both labor and supply chain constraints, as well as our investments for long-term growth. We continue to make investments for long-term growth of the company by building out our RadHard capabilities in Minnesota and heterogeneous integration capabilities in Florida. Both programs are expected to be long-term growth drivers but are near-term headwinds to profitability. In the first quarter of 2022, depreciation related to the RadHard program was $1.5 million, and we incurred $2.8 million in costs of revenue for Florida when excluding tool costs. This compares to a combined $4.4 million in the prior quarter and $1.7 million in the first quarter of 2021. Despite these increases, our first quarter gross margin improvement compared to fourth quarter 2021 is consistent with our prior expectations for a return to gross profitability in the mid $40 million range for quarterly revenues. Further, we expect stronger gross profit flow through off of this baseline as we progress through the forthcoming quarters and years. GAAP R&D for the first quarter was $2.3 million compared to $1.9 million in the first quarter of 2021. Non-GAAP R&D was $2 million in the first quarter of 2022 compared to $1.9 million in the prior year's first quarter. GAAP SG&A was $11.6 million compared to $8.6 million in the first quarter last year. The increase was driven primarily by public company costs and stock-based compensation. Non-GAAP SG&A was $9.7 million in the first quarter of 2022 compared to $8.2 million last year. Adjusted EBITDA was a loss of $4.8 million, declining from a positive $5.6 million in the first quarter of last year and flat with the fourth quarter of last year, reflecting the increased cost of revenue and the negative gross margin on the Infineon WIP recognized in the first quarter 2021 revenue. Cash used in operations during Q1 was $10.7 million. We invested $4.4 million in CapEx this quarter on fab maintenance and improvements. We ended the quarter with $6.4 million in cash and cash equivalents. Total debt outstanding was $69 million as of April 3, 2022, which includes $34 million for our revolver and $35 million for our variable interest entities, excluding unamortized debt issuance costs. Total inventory at the end of Q1 was $13.1 million, compared to $17.5 million at year-end 2021. Q1 2022 ending inventory reflects the $11 million adjustment for Infineon, offset by increased inventory purchases in support of anticipated revenue growth. As you update your Skywater models, the following is some additional color for our expected operating costs for the remainder of fiscal 2022. Quarterly research and development expenses are anticipated in the $2.1 to $2.4 million range, excluding stock-based compensation. Quarterly SG&A expenses are expected to be approximately $10 to $10.4 million, excluding stock-based compensation. And finally, we anticipate annual stock-based compensation to be approximately $9.1 to $9.4 million for fiscal 2022. With that, I'll turn the call back to Claire and welcome your questions on Skywater.
spk00: Thank you, Steve. Our upcoming investor activities include the Oppenheimer Virtual Emerging Growth Conference on May 10th, the Cowen Technology Conference in New York on June 2nd, and the CEO Summit in San Francisco on July 13th. Please visit the investor relations section of our website for other upcoming presentations. Operator, please open the line for questions.
spk04: Thank you. As a reminder, if you'd like to ask a question, please press star then 1 on your telephone keypad. Our first question is from Raji Gill with Needham & Company. Your line is open.
spk06: Yes, thank you, and congrats on the progress on the gross margins turning positive on a non-GAAP basis. That's really good to see, as well as the good progress on the design programs. So just a follow-up on the wait for revenue and the $8.2 million revenue that was pulled in from the new agreement with Infineon. So it seems like this is a combination of a new accounting revenue recognition policy to recognize the revenue over time in the current quarter as well as the higher ASPs related to the contracts. So when we look at then the way for revenue going forward, how do we think about that type of revenue on a kind of a quarterly basis? If we take out the $8 million, the way for revenue was about $13 million. So we'd be expecting kind of sequential growth off that base of revenue. Just want to get some clarity there. Thank you.
spk03: Hey, good afternoon. It's Steve Manko here, and great question on that. I really want to make sure everyone understands what happened there. Your understanding of the information is actually correct. What happened was it was a combination of the timing of when the quarter ended, this contract went into place, and we kind of got the benefit of having some wafer shipping and also recognizing the upfront revenue for the wafers that were in process. So if you're looking at it for the second quarter, I think you're looking at it in the appropriate fashion. Looking at our Q1 wafer services revenue, backing out the $8.2 million, which was the one-time pull-in, and basing growth for second quarter and beyond off of that baseline of about $13.2 or $13.3 million. Obviously, going forward off of that amount, we would expect some increases from improved efficiency, as well as the enhanced price that was built into the contract as well.
spk06: Got it. That's helpful. And then in terms of the gross margins inflecting positive on a non-GAAP basis, when you include the tool revenue and then the ESO, et cetera, you mentioned that at mid-40s, you'll be able to have a positive gross margin. As we go throughout the year, what do you think is going to be the biggest driver to kind of gross profit fall through? Is it going to be continuation and just more wafer volume, better mix? Just if you could walk me through some of the drivers of gross profit fall through as we progress hopefully off this base of gross profits.
spk02: Yeah, I think one thing to keep in mind is that we had a higher mix of way for services this quarter because of the new pricing as well as the adjustment as we get into the out quarters starting in Q two, you're going to see more of the traditional mix of two thirds, one third, two thirds being ATS and obviously that will drive higher gross margins and then the other efficiencies that we'll get once we break through the mid forties and Again, more flow through the revenue dollars to the bottom line. Thank you.
spk04: Our next question is from Mark Lepasas with Jefferies. Your line is open.
spk07: Hi. Thanks for taking my question. A follow-up on the Revenue recognition for wafer services. So, Steve, are all the wafer services revenues now put into this bucket of non-cancellable and therefore recognizable as you generate the WIP? Or is it just portions of that business that fall into that bucket?
spk03: Great question. Great question. It would only be a portion of our wafer services revenue. Really what we could look at is if you look at the balance sheet, given the fact that we really have inventory still reflected on the balance sheet, that's an indication that we are still recognizing revenue for the non-Infinian related wafers at a point in time. So it's really just related to this specific contract for these wafers with Infineon. Something we've been working for, not only to get to market pricing on that product, but also gives us better visibility. Obviously, negotiating for non-cancellable features for those POs coming in is really a good step forward on our direction for the near-term growth of the company. And it is for all the products that we make.
spk07: I'm sorry, Tom, could you say that again?
spk02: Yeah, it is for all the Infineon products that we make. Gotcha. Okay.
spk07: So, I mean, it seems to me that, you know, any product that comes out of ATS that would migrate to wafer services, that would be – those would be like highly customized wafers that might also be considered, you know, not fungible or not cancelable. So I'm wondering if that is – if this is a feature – that you have with Infineon that you start with Infineon that you expect to kind of put to the rest of your programs that run through waiver services.
spk02: Yeah, absolutely correct, Mark. So remember going back to our taker pay with Cypress, we were basically getting paid when the wafer shipped. And then we had a period of around 18 months between when the taker pay ended and this new contract, which remained in that fashion. The model for Skywater going forward is clearly the pay-as-you-go approach, which is applied to not only wafer services, but also a lot of our new contracts for ATS.
spk07: Got you. Okay, that's helpful. And, Steve, another one on the accounting mechanics. So the wafer services were up $7 million. The deferred revenues were up $2.5 million. So is that the accounting mechanics, or does that imply that you actually shipped $4.5 million of that whip that you recognize as revenues, or is there a different – way to think about the accounting mechanics around those waivers.
spk03: That's right. So really the WIP, the 8.2, really what that means is at that point in time when we closed our books on April 3rd, none of that 8.2 was shipped at that point in time. That would just be WIP that is in various stages of processing. in the FAB. You know, the way I think about it is now it gives us some flexibility that I can take one wafer and move that one step, or I can also take five wafers and, sorry, one wafer and move it five steps or five wafers and move it one step. I kind of get the same revenue recognition. So it gives me better visibility and better flexibility on how I optimize the mix in my FAB and prioritize my time in the FAB on moving ATS and wafer services programs throughout.
spk07: Okay, gotcha. All right. And then, Tom, last question for you. So you expressed optimism about the Rad Hard Ramp this year, and then also you mentioned power products and heterogeneous products. So is the Rad Hard Ramp this year, is that going to be production, kind of production, solutions that you're delivering to your customers that are going into their production systems? Or is this like the testing phase still? And when would you expect to see power products and heterogeneous products, you know, hit your top line? And that's a lot. Thank you.
spk02: Great question, Mark. So on Rad Hard, what we are doing is we've completed the development phase and are going into productization and qualification. So we expect revenue to ramp. These won't be product wafers driving revenue, but program revenues as we move through. the qualification sequence that our customers will be putting the devices through as they go through their own qualifications into the final systems. So we're moving to what's considered the next phase in these uh... government funded programs to very important days because the the next round of investment is setting the stage for actual products are being put in systems uh... which will be occurring you know as we exit uh... the twenty three time frame and going to twenty four and again there are some programs that are replacement parts they have a longer qualification cycle uh... we do have some uh... designs that were anticipating to go into this platform that would actually be qualified earlier. So the whole point of the next phase is to prepare for a product shipment of wafers. And it's an important, again, milestone because the government is further investing in the program to prepare for production. As far as power, we continue to see great traction with this platform, the A&D platform. In the market, we have samples going out to the OEMs. They're beginning to go through their own qualification processes. We do have a lead customer that's driving that. And we anticipate to start ramping that in the second half of this year. And then in heterogeneous integration, a lot of that is still in the ATS side of the equation. We're making good progress on all three fronts. The IBEST program is, again, a DOD-funded initiative, and that is moving ahead of schedule. The DECA program is for wafer fan out packaging. There we'll be doing test chips that will go out to customers in the second half of this year. And then, as mentioned, we're also working with Rockley. on their platform, which includes not only the wafer fabrication we're doing up here, but also some additional processing down in Florida. That's the one that has the quickest potential to go to wafer services revenue as we prepare to ramp that program based on their schedules. And then finally, the wafer bonding technology, that's definitely still in the development phase, but we do have a lead target customer that we'll be talking more about as the year unfolds that will drive that program again through ATS. And then as we get into the early part of next year, we'll start seeing vapor services revenue for that as well.
spk07: Very helpful. Thank you.
spk04: Again, please press star 1 if you'd like to ask a question. Our next question is from Krish Sankar with Cowan. Your line is open.
spk05: Hi, thank you for taking the question and congrats, Tom. It's been nice to see a positive growth margin for change. I just had a couple of questions just to clarify. Tom, you mentioned you expect sequential revenue growth as the quarter's progress this year. Was this off the baseline of $48 million in March or was it off of $40 million backing out the $8.2 million from Insignia and Pullen?
spk02: Yeah, it's definitely the latter. So, you know, what we continue to do is drive, you know, growth in our ATS business. And, of course, we did pull in because we had to recognize all the whip. There was a pull in of some of the revenue that would have materialized in Q2, Q3. That's why we're targeting somewhere in the mid-40s is what we're anticipating. So when you pull that out, there will be sequential growth, but it won't be off the $48 million base. Got it, got it.
spk05: And then, you know, the 25% growth for this year, does that still include the $15 million push out from last year due to government funding?
spk02: Yeah, so I want to make sure I hear that again. Say that last part again.
spk05: The 25% revenue growth for this year, does that include the $15 million that was pushed out from last year due to government funding?
spk02: Yes, yes, it does.
spk05: Okay, cool. All right. Awesome. And then one other question I just wanted to check in is that, you know, on the Florida FAB, it seems like, you know, you said it's progressing and then you're working on heterogeneous integration and everything. I'm just kind of curious, like, you know, you spoke about the depreciation on the Florida FAB, which was actually lower in the March quarter compared to the prior quarter. How should we think about it as you start ramping all the wafer-to-wafer bonding and HIV-related activities? Is that depreciation going to start increasing, or the capex related to it going to start increasing for the Florida fab?
spk03: Yeah, so when we talked about that, the depreciation, again, really relates to the Radhard FAB that we have up here in Skywater, Minnesota. So both elements are investments. The Radhard is an investment. Heterogeneous integration in Florida is an investment, both going through my cost of revenue. The difference being that Radhard is depreciation where the heterogeneous integration costs are more so the operating costs flowing through. So that's not depreciation. So I want to remind you of that. But really, those are at baseline levels in Florida for heterogeneous integration. As we continue to ramp that, I would expect those costs to increase as there's more programs moving into Florida, more revenue visibility. And like we said, those programs, whether it's in Minnesota or Florida, The ATS programs start off small and ramp over time. So as they ramp, they would need more headcount focusing on them and growing as well. So as the revenues grow with heterogeneous integration, I would expect those expenses and cost of revenue to grow as well.
spk05: Got it. Super helpful. And then just one last question, Steve. Can you just remind us again on the FY22 what you guided for R&D, SG&E, and stock comp? I didn't get it completely.
spk03: Yeah, let me go back to that. Copy the description for me. Oh, wait a sec. The stock count for the year was $9.9 million. For FY22? For FY22 for the year.
spk05: And R&D was 2.1 to 2.4 per quarter? 2.1 to 2.4 per quarter.
spk03: I got to make sure I'm backing out the stock-based compensation from the SG&A. One second. SG&A was 10.0 to 10.4 for the quarter.
spk05: And that's like the way to model it over the next few quarters, right?
spk03: Yeah, that would be my expectation.
spk05: Got it. Thank you very much. I really appreciate it.
spk03: No problem.
spk04: The next question is from Richard Shannon with Greg Callum. Your line is open.
spk08: Well, thanks, guys, for taking my questions. I'm glad to be here on the call. Congratulations. A good quarter. Let's hear a couple questions here. I think I'll start off with the new frame agreement with Infineon. I think you can characterize the level of appreciation in ASPs and kind of characterize in terms of margins here fully baked, you know, using the appreciation you have in place. Is this something that's now close to, you know, close to 0% gross margins or still a little bit negative here? Any way you can characterize that would be great, please.
spk03: Yeah, when we look at it from an overall perspective, we focus on activities and margin per activity. So we really don't look at it from one individual component. Again, with what we're doing in opening up our FAB for the ATS services, there's ATS programs going through that don't allow us to run a full FAB just focusing on high-volume manufacturing. So really what we do is we focus on how can we get each activity to be the most profitable activity in the fab. That's why, as I mentioned earlier, having us be able to recognize revenue on that activity takes the burden off of making sure we get the wafer all the way through to production in that quarter to recognize the revenue. We can really just focus on maximizing now the revenue per activity and the margin per activity. With that now and the cost that we saw come through, pulling in 10.8 of cost on 8.2 of revenue, because of that, that would have a fully baked cost with all of our depreciation as it currently stands flowing through. And a lot of the depreciation that goes back to the acquisition back in 2017, that will start to come off towards the end of 2013 and into the first quarter of 2014. sorry, 2024, so opportunities to expand our margin at that point in time. So with that pricing and with that cost, it does have our depreciation fully baked into that, as you mentioned.
spk02: And I'll just add, we certainly went after more aggressive pricing on those legacy platforms, and we achieved that. But our business is really to drive not only our ATS programs and a way for services, but creating a much richer mix of uh... within wait for services because all those eight years
Disclaimer